HCID 21884567, 화합물 → HCID 21884491, 화합물
반응식
[N+:1]([C:4]1[CH:5]=[CH:6][C:7]([O:25][CH2:26][C:27]2[CH:31]=[CH:30][O:29][CH:28]=2)=[C:8]([C:10]2[O:11][C:12]3[CH:18]=[CH:17][C:16]([C:19]4[CH:24]=[CH:23][CH:22]=[CH:21][CH:20]=4)=[CH:15][C:13]=3[N:14]=2)[CH:9]=1)([O-])=O>[Zn]>[NH2:1][C:4]1[CH:5]=[CH:6][C:7]([O:25][CH2:26][C:27]2[CH:31]=[CH:30][O:29][CH:28]=2)=[C:8]([C:10]2[O:11][C:12]3[CH:18]=[CH:17][C:16]([C:19]4[CH:20]=[CH:21][CH:22]=[CH:23][CH:24]=4)=[CH:15][C:13]=3[N:14]=2)[CH:9]=1참가 물질
3
시약·촉매·용매 1
실험 절차
Prepared by the method of Example 47b), from 2-(5-nitro-2-(3-furanylmethoxy)phenyl)-5-phenylbenzoxazole (392 mg, 0.95 mmol) and zinc (622 mg, 9.5 mmol) the subtitle compound was obtained (382 mg, 93%). The product was used directly in the next step without purification.
출처 및 근거
- ORD 기록
- ord-ecbab0aacaa446dfa1338f3e92e1b89a
- 출처 데이터셋
- uspto-grants-2006_11
- 특허 번호
- US07138425B2
반응 노트
불러오는 중…